Literature DB >> 9544911

A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype.

A A Morris1, S E Olpin, M Brivet, D M Turnbull, R A Jones, J V Leonard.   

Abstract

Carnitine-acylcarnitine translocase deficiency, a rare beta-oxidation defect, is manifest in most cases by cardiomyopathy and death in early childhood. We report an affected patient, 3 years of age, who has had no serious complications. The residual enzyme activity in fibroblasts was higher than in previously reported patients, which may explain the benign clinical course.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544911     DOI: 10.1016/s0022-3476(98)70030-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Defects in activation and transport of fatty acids.

Authors:  M Brivet; A Boutron; A Slama; C Costa; L Thuillier; F Demaugre; D Rabier; J M Saudubray; J P Bonnefont
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.

Authors:  R Parini; F Invernizzi; F Menni; B Garavaglia; D Melotti; M Rimoldi; S Salera; C Tosetto; F Taroni
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

3.  Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature.

Authors:  Isidro Vitoria; Elena Martín-Hernández; Luis Peña-Quintana; María Bueno; Pilar Quijada-Fraile; Jaime Dalmau; Sofia Molina-Marrero; Belén Pérez; Begoña Merinero
Journal:  JIMD Rep       Date:  2015-01-23

Review 4.  Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.

Authors:  D Galron; O S Birk; A Kazanovitz; S W Moses; E Hershkovitz
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 5.  Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review.

Authors:  Hui-Ming Yan; Hao Hu; Aisha Ahmed; Bing-Bing Feng; Jing Liu; Zheng-Jun Jia; Hua Wang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China.

Authors:  Duo Zhou; Yi Cheng; Xiaoshan Yin; Haixia Miao; Zhenzhen Hu; Jianbin Yang; Yu Zhang; Benqing Wu; Xinwen Huang
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

7.  Transcriptional Regulation of the Mitochondrial Citrate and Carnitine/Acylcarnitine Transporters: Two Genes Involved in Fatty Acid Biosynthesis and β-oxidation.

Authors:  Vito Iacobazzi; Vittoria Infantino; Ferdinando Palmieri
Journal:  Biology (Basel)       Date:  2013-01-29

Review 8.  Carnitine Inborn Errors of Metabolism.

Authors:  Mohammed Almannai; Majid Alfadhel; Ayman W El-Hattab
Journal:  Molecules       Date:  2019-09-06       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.